Literature DB >> 11158038

Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.

R Chadarevian1, E Bruckert, L Leenhardt, P Giral, A Ankri, G Turpin.   

Abstract

T(4) levels are determinant of several components of the fibrinolytic system. However, relationships between hypothyroidism and alteration of fibrinolytic capacity are not well established, and published data remain conflicting. As the impact of hypothyroidism on both degradation and synthesis of proteins may vary according to the severity of the disease, we measured fibrinolytic activity across varying states of hypothyroidism. We measured fibrinogen, D-dimers (DDI), alpha(2)-antiplasmin activity, tissue plasminogen activator antigen (t-PA Ag), plasminogen, plasminogen activator inhibitor antigen (PAI-1 Ag), and factor XII (FXII) of the coagulation. We prospectively included 76 middle-aged female subjects: 25 controls, 24 patients displaying moderate hypothyroidism (TSH, 10--50 mU/L), and 27 patients with severe hypothyroidism (TSH, >50 mU/L). Blood pressure, body mass index, smoking habits, total cholesterol as well as high and low density lipoprotein subfractions, triglyceride, fasting glycemia, and insulinemia were recorded. We found a different pattern of fibrinolytic abnormalities according to the severity of hypothyroidism. Compared with controls, patients with moderate hypothyroidism displayed a decreased fibrinolytic activity, as reflected by lower DDI levels, higher alpha(2)-antiplasmin activities, and higher levels of t-PA and PAI-1 Ag. In sharp contrast, patients with severe hypothyroidism exhibited higher DDI levels, lower alpha(2)-antiplasmin activities, and lower t-PA and PAI-1 Ag levels. These results were not accounted for by confounding factors such as age, smoking, and components of the insulin resistance syndrome. Free T(4) was significantly associated with fibrinogen, alpha(2)-antiplasmin, PAI-1 Ag, total cholesterol, and triglyceride and was negatively associated with DDI. The main hypotheses underlying the mechanisms by which thyroid status may affect the fibrinolytic system remain to be established. In conclusion, patients with moderate hypothyroidism, who were consistently shown to be at high risk for cardiovascular disease, have decreased fibrinolytic activity. Subjects with severe hypothyroidism have a tendency toward increased fibrinolytic activity, and these modifications may participate to the bleeding tendency observed in such patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158038     DOI: 10.1210/jcem.86.2.7221

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  37 in total

1.  Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients.

Authors:  Erhan Tatar; Fatih Kircelli; Gulay Asci; Juan Jesus Carrero; Ozkan Gungor; Meltem Sezis Demirci; Suha Sureyya Ozbek; Naim Ceylan; Mehmet Ozkahya; Huseyin Toz; Ercan Ok
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 8.237

Review 2.  Thyroid-associated autoimmune coagulation disorders.

Authors:  Massimo Franchini; Giuseppe Lippi; Franco Manzato; Pier Paolo Vescovi
Journal:  J Thromb Thrombolysis       Date:  2009-03-10       Impact factor: 2.300

3.  Assessment of the Impact of L-Thyroxine Therapy on Bleeding Risk in Patients Receiving Vitamin K Antagonists.

Authors:  Farès Moustafa; Rémi Malhomme; Bruno Pereira; Alain Barres; Jennifer Saint-Denis; Frederic Dutheil; Marie Batisse; Jeannot Schmidt
Journal:  Clin Drug Investig       Date:  2017-10       Impact factor: 2.859

4.  Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.

Authors:  Cihangir Erem; Ozge Ucuncu; Mustafa Yilmaz; Mustafa Kocak; Irfan Nuhoglu; Halil Onder Ersoz
Journal:  Endocrine       Date:  2008-10-29       Impact factor: 3.633

Review 5.  Thyroid, hemostasis and thrombosis.

Authors:  F Marongiu; C Cauli; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

6.  Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism.

Authors:  R Chadarevian; C Jublanc; E Bruckert; P Giral; A Ankri; L Leenhardt; J Chapman; G Turpin
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

7.  Hypothyroidism and mortality among dialysis patients.

Authors:  Connie M Rhee; Erik K Alexander; Ishir Bhan; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-20       Impact factor: 8.237

8.  Hypothyroidism and cerebral vein thrombosis--a possible association.

Authors:  Ana Rita Peralta; Patrícia Canhão
Journal:  J Neurol       Date:  2008-06-20       Impact factor: 4.849

Review 9.  Hypothyroidism as a risk factor for cardiovascular disease.

Authors:  Bernadette Biondi; Irwin Klein
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

10.  No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque.

Authors:  A P Delitala; F Filigheddu; M Orrù; M AlGhatrif; M Steri; M G Pilia; A Scuteri; M Lobina; M G Piras; G Delitala; E G Lakatta; D Schlessinger; F Cucca
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-10-21       Impact factor: 4.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.